Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Parkinson's Disease

  Free Subscription

Articles published in Science

Retrieve available abstracts of 18 articles:
HTML format

Single Articles

    April 2021
    How dopamine leads to hallucinations.
    Science. 2021;372:33-34.

    October 2020
  2. BARTELS T, De Schepper S, Hong S
    Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases.
    Science. 2020;370:66-69.
    PubMed     Abstract available

    September 2020
  3. SINHA G
    Trials begin for a new weapon against Parkinson's: light.
    Science. 2020;369:1415-1416.

    March 2020
  4. GRASBY KL, Jahanshad N, Painter JN, Colodro-Conde L, et al
    The genetic architecture of the human cerebral cortex.
    Science. 2020;367.
    PubMed     Abstract available

    June 2019
  5. O'NEILL C
    Gut microbes metabolize Parkinson's disease drug.
    Science. 2019;364:1030-1031.

    April 2019
  6. LIU Y, Aguzzi A
    Immunotherapy for neurodegeneration?
    Science. 2019;364:130-131.

    November 2018
  7. BRUNDIN P, Wyse R
    Cancer enzyme affects Parkinson's disease.
    Science. 2018;362:521-522.

  8. KAM TI, Mao X, Park H, Chou SC, et al
    Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson's disease.
    Science. 2018;362.
    PubMed     Abstract available

    August 2018
    Probing new targets for movement disorders.
    Science. 2018;361:462.

    April 2018
  10. ARKINSON C, Walden H
    Parkin function in Parkinson's disease.
    Science. 2018;360:267-268.

  11. ALESSI DR, Sammler E
    LRRK2 kinase in Parkinson's disease.
    Science. 2018;360:36-37.

    December 2017
  12. FUSCO G, Chen SW, Williamson PTF, Cascella R, et al
    Structural basis of membrane disruption and cellular toxicity by alpha-synuclein oligomers.
    Science. 2017;358:1440-1443.
    PubMed     Abstract available

    September 2017
  13. BURBULLA LF, Song P, Mazzulli JR, Zampese E, et al
    Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.
    Science. 2017 Sep 7. pii: eaam9080. doi: 10.1126/science.aam9080.
    PubMed     Abstract available

  14. MITTAL S, Bjornevik K, Im DS, Flierl A, et al
    beta2-Adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson's disease.
    Science. 2017;357:891-898.
    PubMed     Abstract available

    April 2017
  15. SHIELDS BC, Kahuno E, Kim C, Apostolides PF, et al
    Deconstructing behavioral neuropharmacology with cellular specificity.
    Science. 2017;356.
    PubMed     Abstract available

    November 2016
  16. WADMAN M
    Rogue protein's partners offer hope in Parkinson's disease.
    Science. 2016;354:956.

    September 2016
  17. MAO X, Ou MT, Karuppagounder SS, Kam TI, et al
    Pathological alpha-synuclein transmission initiated by binding lymphocyte-activation gene 3.
    Science. 2016;353.
    PubMed     Abstract available

  18. JUCKER M, Heikenwalder M
    Immune receptor for pathogenic alpha-synuclein.
    Science. 2016;353:1498-1499.

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.